Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure

The aim of this study is to investigate the impact of a topical product on skin health and aging

Participants needed: 30
Trial details
Age: 45-65Biological sex: AllType: InterventionalSponsor: Amazentis SAUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Written Informed Consent to participate in the study [+7]

Female participants: Pregnancy or lactation [+18]

Status: Not yet recruiting

Cerebrospinal Fluid Kinetics of Urolithin A

The purpose of this study is to determine the impact of Mitopure® consumption on urolithin A (UA) kinetics in cerebral spinal fluid (CSF).

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Amazentis SAUpdated: Apr 13, 2026Locations: 1
Eligibility criteria

1. Healthy male and female participants aged between 18 and 45 years (both inclu... [+14]

1. Known hypersensitivity to Urolithin A or related product or any component of... [+20]

Status: Recruiting

The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults

This is a randomised, double-blind, placebo-controlled, parallel study to assess the effects of Urolithin A (Mitopure®) supplementation on muscle strength and performance in healthy middle-aged adults. Participants will be randomized to consume Mitopure® (500 mg), Mitopure® (1000 mg), or placebo once daily for 6 months.

Participants needed: 120
Trial details
Age: 40-65Biological sex: AllType: InterventionalSponsor: Amazentis SAUpdated: Mar 31, 2026Locations: 1
Eligibility criteria

1. Be able to give written informed consent. [+7]

1. Participants who are pregnant or wish to become pregnant during the study or... [+32]

Status: Recruiting

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Participants needed: 250
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Amazentis SAUpdated: Sep 8, 2025Locations: 1
Eligibility criteria

Males and females 18 to 80 years of age; [+3]

Women who are pregnant, breastfeeding, or planning to become pregnant during the... [+8]